Skip to content
value.today

Medifast, Inc.: financial analysis

Ratios worked out from 10 fiscal years of Medifast, Inc.'s statements, compared with 16 companies in Consumer Services.

Operating margin, 2025
-3.7%
Consumer Services: 13.7%
Return on equity, 2025
-9.1%
Consumer Services: 21.1%
Revenue growth, 3 years a year, 2025
-37.7%
Consumer Services: 4.2%
Free cash flow margin, 2025
0.3%
Consumer Services: 9.6%

Medifast, Inc. scorecard#

Passes 8 of the 25 checks that could be worked out: strongest in financial health (3 of 3), weakest in growth (0 of 6). Fiscal year 2025; market cap of Oct 19, 2026.

  • Valuation2 of 6
    • ✗P/E below its peers' medianNo P/EThe company made a loss over the last twelve months.
    • ✓Price to book below its peers' median0.7×Price to book 0.7× against Consumer Services's median of 2.4×.
    • ✓Price to sales below its peers' median0.4×Price to sales 0.4× against Consumer Services's median of 1.3×.
    • ✗Free cash flow yield above 5%0.9%Free cash flow is 0.9% of the market value.
    • ✗Earnings yield above the 10-year Treasury yieldLossA loss earns nothing against the 10-year Treasury's 5.15% (2026-11-13).
    • ✗The price assumes slower growth than the last three years'-24.0%The price assumes -24.0% a year for ten years; revenue grew -37.7% a year over the last three.
  • Growth0 of 6
    • ✗Revenue grew in the newest year-36.0%Revenue down 36.0% in fiscal 2025.
    • ✗Revenue up more than 5% a year over three years-37.7%-37.7% a year over the three years to fiscal 2025.
    • ✗Faster growth over three years than its peers' median-37.7%-37.7% a year against Consumer Services's median of 4.2% (8 companies).
    • ✗Earnings per share grew in the newest year-1.70 vs 0.19Diluted EPS -1.70 in fiscal 2025 against 0.19 the year before (report's currency).
    • ✗Net income higher than five years earlier-$19 M-$19 M in fiscal 2025 against $103 M in 2020.
    • ✗Revenue rose in at least four of the last five years2 of 5Revenue rose in 2 of the five years to fiscal 2025.
  • Profitability0 of 5
    • ✗Profitable in the newest year-$19 MNet income -$19 M in fiscal 2025.
    • ✗Profitable in each of the last five years4 of 5Profitable in 4 of the five years to fiscal 2025.
    • ✗Operating margin above its peers' median-3.7%-3.7% against Consumer Services's median of 13.7% (12 companies).
    • ✗Return on equity above 15%-9.1%-9.1% in fiscal 2025.
    • –Return on invested capital above 10%No return on invested capital on file.
    • ✗Operating margin wider than three years earlier-3.7%-3.7% in fiscal 2025 against 11.6% in 2022.
  • Financial health3 of 3
    • ✓Short-term assets cover short-term liabilities4.7×Current ratio 4.69 at the end of fiscal 2025.
    • –Debt below equityDebt or equity is not on file (or equity is negative).
    • –Net debt below three years of EBITDANet debt to EBITDA is not on file.
    • –Operating income covers interest five timesInterest expense is not on file.
    • ✓Cash from operations positive in each of the last three years3 of 3Positive in 3 of the three years to fiscal 2025.
    • ✓Altman Z-score outside the distress zone4.65Z-score 4.65 (safe zone) for fiscal 2025.
  • Shareholder returns3 of 5
    • ✓Pays a dividendYesPaid dividends in fiscal 2025.
    • ✗Dividend per share raised five years in a row2 of 5Dividend per share raised in 2 of the five years to fiscal 2025.
    • –Dividends under 75% of net incomeNo payout ratio (a loss year).
    • ✓Share count up no more than 2% in a year0.2%Diluted shares up 0.2% in fiscal 2025.
    • ✗Dividends and buybacks above 3% of the market value0.1%Dividends and buybacks were 0.1% of the market value.
    • ✓Free cash flow covers dividends and buybacks$1 MFree cash flow $1 M against $0 M paid out in fiscal 2025.

Worked out from the statements as filed (sec), the medians of Consumer Services, the 10-year Treasury yield of Nov 13, 2026 and the market cap. A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work

What the 2025 statements show#

Each line is an observation with its numbers, not a judgement of the company.

Strengths

  • Free cash flow has been positive 17 years in a row.

Worth a look

  • Revenue fell 36.0% against the year before.
  • Net loss of $19 million.

Piotroski F-score

Nine yes/no tests of whether the company's finances improved in the year. One point each.

3of 8(1 of the nine tests cannot be worked out from the statements on file, so there is no full score)
  • Made a profitno
  • Operations brought in cashyes
  • Return on assets roseno
  • Cash from operations exceeds profityes
  • Long-term debt fell against assetsnot on file
  • Current ratio roseyes
  • No new shares issuedno
  • Gross margin roseno
  • Asset turnover roseno

Altman Z-score

A 1968 formula that weighs five balance-sheet ratios. It was built on listed manufacturers and says less about other kinds of company.

4.65Safe zone(above 2.99, where the formula's author found few failures)
The five parts of the Altman Z-score
PartRatioWeightPoints
Working capital to assets0.64× 1.20.77
Retained earnings to assets0.64× 1.40.89
Operating income to assets-0.06× 3.3-0.19
Market value to liabilities2.71× 0.61.63
Revenue to assets1.56× 11.56

Profitability#

Medifast, Inc.: profitability by fiscal year
Fiscal yearTrend20252024202320222021Median of peersAhead of
Gross margin71.3%73.8%72.4%71.3%73.9%44.3%100%
Operating margin-3.7%0.5%11.8%11.6%14.2%13.7%0%
Net margin-4.8%0.4%9.3%9.0%10.8%10.1%0%
Return on equity-9.1%1.0%55.8%80.3%91.2%21.1%0%
Return on assets-7.0%0.7%31.8%40.2%48.6%5.7%0%

Growth#

Medifast, Inc.: growth by fiscal year
Fiscal yearTrend20252024202320222021Median of peersAhead of
Revenue growth-36.0%-43.8%-32.9%4.8%63.3%6.7%0%
Revenue growth, 3 years a year-37.7%-26.6%4.7%30.8%45.0%4.2%0%
Revenue growth, 5 years a year-16.2%-3.3%16.4%39.6%40.9%4.9%0%
Net income growth——-30.8%-12.5%59.5%6.6%—
Earnings per share growth——-28.5%-8.4%60.0%13.3%—

Financial strength#

Medifast, Inc.: financial strength by fiscal year
Fiscal yearTrend20252024202320222021Median of peersAhead of
Current ratio4.69×3.34×2.43×1.58×1.81×0.98×100%
Equity share of assets80.2%73.9%65.0%49.0%50.8%34.9%100%

Cash#

Medifast, Inc.: cash by fiscal year
Fiscal yearTrend20252024202320222021Median of peersAhead of
Free cash flow$1 M$17 M$141 M$178 M$60 M$174 M0%
Free cash flow margin0.3%2.8%13.2%11.1%4.0%9.6%0%
Cash conversion—1,171.3%148.5%135.5%57.6%173.8%—
Capital spending share of revenue1.5%1.2%0.6%1.0%2.2%1.9%—

Shareholder returns#

Medifast, Inc.: shareholder returns by fiscal year
Fiscal yearTrend20252024202320222021Median of peersAhead of
Dividend yield0.2%————1.6%0%
Buyback yield0.0%————4.1%0%
Shareholder yield0.2%————3.4%0%
Dividend payout—34.5%73.5%49.9%38.9%——
Change in share count0.2%0.4%-3.2%-4.6%-0.3%-0.0%38%

Efficiency#

Medifast, Inc.: efficiency by fiscal year
Fiscal yearTrend20252024202320222021Median of peersAhead of
Asset turnover1.45×2.03×3.42×4.47×4.53×0.97×93%

How each figure is worked out#

Gross margin
Gross profit as a share of revenue.
Operating margin
Operating income as a share of revenue.
Net margin
Net income as a share of revenue.
Return on equity
Net income as a share of shareholders' equity (the average of the start and the end of the year). Not given when equity is negative.
Return on assets
Net income as a share of total assets (average of the year).
Revenue growth
Revenue against the year before.
Revenue growth, 3 years a year
The yearly rate that takes revenue of three years earlier to this year's.
Revenue growth, 5 years a year
The yearly rate that takes revenue of five years earlier to this year's.
Net income growth
Net income against the year before. Only when both years were profitable.
Earnings per share growth
Diluted earnings per share against the year before. Only when both were positive.
Current ratio
Assets due within a year divided by liabilities due within a year.
Equity share of assets
Shareholders' equity as a share of total assets.
Free cash flow
Cash from operations less capital spending.
Free cash flow margin
Free cash flow as a share of revenue.
Cash conversion
Cash from operations as a share of net income. Only when the year was profitable.
Capital spending share of revenue
Capital spending as a share of revenue.
Dividend yield
Dividends paid in the fiscal year as a share of today's market value.
Buyback yield
Shares bought back in the fiscal year as a share of today's market value.
Shareholder yield
Dividends plus buybacks as a share of today's market value.
Dividend payout
Dividends paid as a share of net income. Only when the year was profitable.
Change in share count
Diluted shares against the year before. Negative: fewer shares.
Asset turnover
Revenue divided by total assets (average of the year).

Source: Medifast, Inc.'s statements: annual reports filed with the SEC. Arithmetic on reported figures, in US dollars; nothing is estimated. A figure is blank when a line it needs is not in the statements on file, and left out when the result cannot be right (a margin from next to no revenue). "Ahead of" is the share of the 16 companies in Consumer Services that Medifast, Inc. is better than on that figure, using each company's newest fiscal year; yields use today's market value. Medians for every industry · Back to Medifast, Inc.